In order to do so, APCs, particularly dendritic cells, process antigens through an exogenous antigen processing pathway where (tumour) cellular material is phagocytosed and converted into HLA class I- and class II-binding peptides that are presented to CD8+ (cross-presentation) and CD4+ T cells, respectively [25]. The gene discussed is CD4; the disease is neoplasm.